AbbVie Inc.ABBV

Market cap
$294B
P/E ratio
60.3x
Dec 31,
2013
Dec 31,
2014
Dec 31,
2015
Dec 31,
2016
Dec 31,
2017
Dec 31,
2018
Dec 31,
2019
Dec 31,
2020
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Revenues18,79019,96022,85925,63828,21632,75333,26645,80456,19758,05454,318
Cost of products sold4,5814,4264,5005,8337,0407,7187,43915,38717,44617,41420,415
Selling, general and administrative5,3527,7246,3875,8556,2757,3996,94211,29912,34915,26012,872
Research and development2,8553,2974,2854,3664,98210,3296,4076,5577,0846,5107,675
Acquired IPR&D and milestones3383521502003274243851,200962697778
Other operating expense (income), net------890--432-56179
Total operating costs and expenses13,12616,54915,32216,25418,62426,37020,28334,44138,27339,93741,561
Operating earnings5,6643,4117,5379,3849,5926,38312,98311,36317,92418,11712,757
Interest expense, net-278-391-686-965-1,004-1,144-1,509-2,280-2,384-2,044-1,684
Net foreign exchange loss-55-678-193-303-348-24-42-71-51-148-146
Other expense, net127-13-232-513-18-3,006-5,614-2,500-2,448-4,677
Earnings before income tax expense5,3322,3696,6457,8847,7275,1978,4263,39812,98913,4776,250
Income tax expense1,2045951,5011,9312,418-490544-1,2241,4401,6321,377
Net earnings-------4,62211,54911,8454,873
Net earnings attributable to noncontrolling interest-------67910
Net earnings attributable to AbbVie Inc.4,1281,7745,1445,9535,3095,6877,8824,62211,54911,8454,873
Earnings Per Share, Basic2.581.113.153.653.313.675.32.736.486.652.73
Earnings Per Share, Diluted2.561.13.133.633.33.665.282.726.456.632.72